Pharmaceutical Business Intelligence Reports
Showing 313–324 of 709 results
-
Drug Patent Reports
LENVIMA Drug Profile, 2024
Original price was: $800.00.$399.00Current price is: $399.00. Add to cart -
Drug Patent Reports
LEQVIO Drug Profile, 2024
Original price was: $800.00.$399.00Current price is: $399.00. Add to cart -
Drug Patent Reports
LEVULAN Drug Profile, 2024
Original price was: $800.00.$399.00Current price is: $399.00. Add to cart -
Excipient Business Development Opportunity Reports
LIGHT MINERAL OIL Drug Excipient Business Development Opportunity Report, 2024
Original price was: $800.00.$399.00Current price is: $399.00. Add to cart -
Drug Patent Reports
LO LOESTRIN FE Drug Profile, 2024
Original price was: $800.00.$399.00Current price is: $399.00. Add to cart -
Drug Patent Reports
LOKELMA Drug Profile, 2024
Original price was: $800.00.$399.00Current price is: $399.00. Add to cart -
Drug Patent Reports
LONSURF Drug Profile, 2024
Original price was: $800.00.$399.00Current price is: $399.00. Add to cart -
Drug Patent Reports
LORBRENA Drug Profile, 2024
Original price was: $800.00.$399.00Current price is: $399.00. Add to cart -
Drug Patent Reports
LOSEASONIQUE Drug Profile, 2024
Original price was: $800.00.$399.00Current price is: $399.00. Add to cart -
Excipient Business Development Opportunity Reports
LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE Drug Excipient Business Development Opportunity Report, 2024
Original price was: $800.00.$399.00Current price is: $399.00. Add to cart -
Drug Patent Reports
LUMASON Drug Profile, 2024
Original price was: $800.00.$399.00Current price is: $399.00. Add to cart -
Drug Patent Reports
LUTATHERA Drug Profile, 2024
Original price was: $800.00.$399.00Current price is: $399.00. Add to cart
